Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACTIVATOR INHIBITOR-1 PAI-1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fredstorp-Lidebring, M; Bendahl, PO; Brunner, N; Casslen, B; Hogberg, T; Langstrom-Einarsson, E; Willen, R; Ferno, M
      Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

      EUROPEAN JOURNAL OF CANCER
    2. Kurtzman, AL; Govindarajan, S; Vahle, K; Jones, JT; Heinrichs, V; Patten, PA
      Advances in directed protein evolution by recursive genetic recombination:applications to therapeutic proteins

      CURRENT OPINION IN BIOTECHNOLOGY
    3. Sprouse, JT; Wong, CS; Chandler, WL; Williams, GD; Watkins, SL; Tarr, PI
      Thrombogenic alleles, Escherichia coli O157 : H7 infections, and hemolyticuremic syndrome

      BLOOD COAGULATION & FIBRINOLYSIS
    4. Silveira, A
      Postprandial triglycerides and blood coagulation

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    5. Epstein, M
      Aldosterone as a mediator of progressive renal dysfunction: Evolving perspectives

      INTERNAL MEDICINE
    6. Konno, H; Abe, J; Kaneko, T; Baba, M; Shoji, A; Sunayama, K; Kamiya, K; Tanaka, T; Suzuki, S; Nakamura, S; Urano, T
      Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    7. Mandl-Weber, S; Haslinger, B; Schalkwijk, CG; Sitter, T
      Early glycated albumin, but not advanced glycated albumin, methylglyoxal, or 3-deoxyglucosone increases the expression of PAI-1 in human peritoneal mesothelial cells

      PERITONEAL DIALYSIS INTERNATIONAL
    8. Smolarz, B; Blasiak, J; Kulig, A; Romanowicz-Makowska, H; Dziki, A; Ulanska, J; Pander, B; Szewczyk, T
      Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    9. Aoki, K; Aikawa, N; Sekine, K; Yamazaki, M; Mimura, T; Urano, T; Takada, A
      Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns

      BURNS
    10. Mandl-Weber, S; Haslinger, B; Lederer, SR; Sitter, T
      Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: Role of interleukin-1 alpha

      AMERICAN JOURNAL OF KIDNEY DISEASES
    11. Epstein, M
      Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

      JOURNAL OF HYPERTENSION
    12. Brooks, TD; Slomp, J; Quax, PHA; De Bart, ACW; Spencer, MT; Verheijen, JH; Charlton, PA
      Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro

      CLINICAL & EXPERIMENTAL METASTASIS
    13. Huang, YH; Liu, CC; Wang, ST; Lei, HY; Liu, HS; Lin, YS; Wu, HL; Yeh, TM
      Activation of coagulation and fibrinolysis during dengue virus infection

      JOURNAL OF MEDICAL VIROLOGY
    14. Noguchi, T; Matsuyama, S; Akao, M; Hagiwara, H; Uno, S; Seki, T; Ariga, T
      Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats

      THROMBOSIS RESEARCH
    15. Egelund, R; Petersen, TE; Andreasen, PA
      A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    16. Nicholls, SC; Chandler, WL; Hoffer, EK
      Thrombolysis failure: A role for plasminogen activator inhibitor type 1 (PAI-1)

      BRITISH JOURNAL OF HAEMATOLOGY
    17. Juhan-Vague, I; Alessi, MC; Morange, PE
      Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity

      ANNALS OF MEDICINE
    18. Blasiak, J; Smolarz, B; Kubryn, I; Kulig, A; Dziki, A; Ulanska, J; Pander, B
      Plasminogen activator inhibitor-1 (PAI-1) level and 4G/5G genetic polymorphism in patients with colorectal cancer

      EXPERIMENTAL ONCOLOGY
    19. Ieko, M; Ichikawa, K; Atsumi, T; Takeuchi, R; Sawada, KI; Yasukouchi, T; Koike, T
      Effects of beta 2-glycoprotein I and monoclonal anticardiolipin antibodieson extrinsic fibrinolysis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    20. Glueck, CJ; Awadalla, SG; Phillips, H; Cameron, D; Wang, P; Fontaine, RN
      Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage

      FERTILITY AND STERILITY
    21. Blasiak, J; Smolarz, B
      Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphismis not associated with breast cancer

      ACTA BIOCHIMICA POLONICA
    22. Loskutoff, DJ; Curriden, SA; Hu, G; Deng, G
      Regulation of cell adhesion by PAI-1

      APMIS
    23. de Maat, MPM; Bladbjerg, EM; Johansen, LG; de Knijff, P; Gram, J; Kluft, C; Jespersen, J
      DNA-Polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit - Is there a relation with the low risk of cardiovascular disease in the Inuit?

      THROMBOSIS AND HAEMOSTASIS
    24. Quattrone, A; Gambardella, A; Carbone, AM; Oliveri, RL; Lavano, A; De Marco, EV; Civitelli, D; Bono, F; Zappia, M; Pardatscher, K; DiMinno, G
      A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertension

      JOURNAL OF NEUROLOGY
    25. Naka, S; Takeshita, K; Yamamoto, T; Tani, T; Kodama, M
      Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation inthe swine acute liver failure model

      ARTIFICIAL ORGANS
    26. Carroll, VA; Binder, BR
      The role of the plasminogen activation system in cancer

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    27. Narayanan, S; Hamasaki, N
      Current concepts of coagulation and fibrinolysis

      ADVANCES IN CLINICAL CHEMISTRY, VOL 33
    28. Nauck, M; Wieland, H; Marz, W
      Rapid, homogeneous genotyping of the 4G/5G polymorphism in the promoter region of the PAII gene by fluorescence resonance energy transfer and probe melting curves

      CLINICAL CHEMISTRY
    29. Harbeck, N; Dettmar, P; Thomssen, C; Berger, U; Ulm, K; Kates, R; Hofler, H; Janicke, F; Graeff, H; Schmitt, M
      Risk group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow up

      BRITISH JOURNAL OF CANCER
    30. MITARAI T
      SYMPOSIUM ON MEDICAL DISEASES AND ANTITHROMBOTIC THERAPY - 3 - ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES ASSOCIATED RENAL DISEASES AND THROMBOTIC MICROANGIOPATHY

      Internal medicine
    31. WILLIAMS KV; KORYTKOWSKI MT
      SYNDROME-X - PATHOGENESIS, CLINICAL AND THERAPEUTIC ASPECTS

      Diabetes, nutrition & metabolism
    32. JANANDDELENNE B; CHAGNAUD C; RACCAH D; ALESSI MC; JUHANVAGUE I; VAGUE P
      VISCERAL FAT AS A MAIN DETERMINANT OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVEL IN WOMEN

      International journal of obesity
    33. FERNHALL B; SZYMANSKI LM; GORMAN PA; MILANI J; PAUP DC; KESSLER CH
      FIBRINOLYTIC-ACTIVITY IS NOT DEPENDENT UPON EXERCISE MODE IN POSTMYOCARDIAL INFARCTION PATIENTS

      European journal of applied physiology and occupational physiology
    34. IMPERATORE G; RICCARDI G; IOVINE C; RIVELLESE AA; VACCARO O
      PLASMA-FIBRINOGEN - A NEW FACTOR OF THE METABOLIC SYNDROME - A POPULATION-BASED STUDY

      Diabetes care
    35. NAGI DK; KNOWLER WC; MOHAMEDALI V; BENNETT PH; YUDKIN JS
      INTACT PROINSULIN, DES-31,32 PROINSULIN, AND SPECIFIC INSULIN CONCENTRATIONS AMONG NONDIABETIC AND DIABETIC SUBJECTS IN POPULATIONS AT VARYING RISK OF TYPE-2 DIABETES

      Diabetes care
    36. HAYASHI T; KAMOGAWA A; RO S; YAMAGUCHI K; KOBAYASHI Y; TAKAHASHI Y; MURAYAMA W
      PLASMA FROM PATIENTS WITH CIRRHOSIS INCREASES TISSUE-PLASMINOGEN ACTIVATOR RELEASE FROM VASCULAR ENDOTHELIAL-CELLS IN-VITRO

      Liver
    37. Yamamoto, K; Loskutoff, DJ; Saito, H
      Renal expression of fibrinolytic genes and tissue factor in a murine modelof renal disease as a function of age

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    38. Aosasa, S; Ono, S; Seki, S; Takayama, E; Tadakuma, T; Hiraide, H; Mochizuki, H
      Inhibitory effect of protease inhibitor on endothelial cell activation

      JOURNAL OF SURGICAL RESEARCH
    39. WOLLENBERG B; JAN NV; JUND R; CHAUBAL S; UNTCH M
      UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 - NEW FUNCTIONAL RISK-FACTORS IN HEAD AND NECK SQUAMOUS-CELL CANCER

      Oncology Reports
    40. LIU YX; CHEN YJ; FENG QA; HU ZY
      ROLE OF PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN LUTEOLYSIS - A MINIREVIEW

      Chinese Science Bulletin
    41. LIU YX; HU ZY; ZOU RJ; OCKLEFORD CD
      IDENTIFICATION OF SECRETION SITES OF TISSUE-PLASMINOGEN ACTIVATOR ANDPLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN BASAL PLATES OF HUMAN AND RHESUS-MONKEY PLACENTAE

      Chinese Science Bulletin
    42. BASTARD JP; BRUCKERT E; GIRAL P; BEUCLER I; ANKRI A; HAINQUE B; TURPIN G
      PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS ARE RELATED TO GAMMA-GLUTAMYL-TRANSFERASE IN HYPERLIPIDEMIC WOMEN

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    43. NADIG C; BINSWANGER U; VONFELTEN A
      IS HEPARIN-THERAPY NECESSARY IN CAPD PERITONITIS

      Peritoneal dialysis international
    44. KOPEIKINA LT; KAMPER EF; KOUTSOUKOS V; BASSIAKOS Y; STAVRIDIS I
      IMBALANCE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND ITS SPECIFIC INHIBITOR (PAI-1) IN PATIENTS WITH RHEUMATOID-ARTHRITIS ASSOCIATED WITH DISEASE-ACTIVITY

      Clinical rheumatology
    45. SALAT C; HOLLER E; WOLF C; KOLB HJ; REINHARDT B; PIHUSCH R; KRAMLING HJ; HEINEMANN V; HALLER M; HILLER E
      LABORATORY MARKERS OF VENOOCCLUSIVE DISEASE IN THE COURSE OF BONE-MARROW AND SUBSEQUENT LIVER-TRANSPLANTATION

      Bone marrow transplantation
    46. OHTANI A; MURAKAMI J; HIRANOWAKIMOTO A
      T-686, A NOVEL INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1, INHIBITS THROMBOSIS WITHOUT IMPAIRMENT OF HEMOSTASIS IN RATS

      European journal of pharmacology
    47. CHO JY; CHUNG HC; NOH SH; ROH JK; MIN JS; KIM BS
      HIGH-LEVEL OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS A NEW PROGNOSTIC MARKER IN PATIENTS WITH GASTRIC-CARCINOMA

      Cancer
    48. HACKEL C; CZERNIAK B; AYALA AG; RADIG K; ROESSNER A
      EXPRESSION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN DEDIFFERENTIATED CHONDROSARCOMA

      Cancer
    49. ZHOU A; PEI Y; WU HH; DONG XY; XU XX
      HIGH-LEVEL EXPRESSION OF ACTIVE HUMAN PLASMINOGEN-ACTIVATOR INHIBITORTYPE-1 (PAI-1) IN ESCHERICHIA-COLI

      Biochemistry and molecular biology international
    50. TAKAHASHI Y; TANAKA T; MINOWA H; OOKUBO Y; SUGIMOTO M; NAKAJIMA M; MIYAUCHI Y; YOSHIOKA A
      HEREDITARY PARTIAL DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ASSOCIATED WITH A LIFELONG BLEEDING TENDENCY

      International journal of hematology
    51. NAGI DK; ALI VM; JAIN SK; WALJI S; YUDKIN JS
      PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ACTIVITY IS ELEVATED IN ASIANAND CAUCASIAN SUBJECTS WITH NON-INSULIN-DEPENDENT (TYPE-2) DIABETES BUT NOT IN THOSE WITH IMPAIRED GLUCOSE-TOLERANCE (IGT) OR NONDIABETIC ASIANS

      Diabetic medicine
    52. PREISSNER KT; DEBOER H; PANNEKOEK H; DEGROOT PG
      THROMBIN REGULATION BY PHYSIOLOGICAL INHIBITORS - THE ROLE OF VITRONECTIN

      Seminars in thrombosis and hemostasis
    53. BASTARD JP; BRUCKERT E; PORQUET D; JARDEL C; ANKRI A; DELATTRE J; HAINQUE B
      EVIDENCE FOR A RELATIONSHIP BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1AND GAMMA-GLUTAMYL-TRANSFERASE

      Thrombosis research
    54. JUHANVAGUE I
      HEMOSTATIC PARAMETERS AND VASCULAR RISK

      Atherosclerosis
    55. HOFMANN R; LEHMER A; BURESCH M; HARTUNG R; ULM K
      CLINICAL RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR, AND ITS INHIBITOR IN PATIENTS WITH RENAL-CELL CARCINOMA

      Cancer
    56. CIERNIEWSKI CS; BABINSKA A; SWIATKOWSKA M; WILCZYNSKA M; OKRUSZEK A; STEC WJ
      INHIBITION BY MODIFIED OLIGODEOXYNUCLEOTIDES OF THE EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN HUMAN ENDOTHELIAL-CELLS

      European journal of biochemistry
    57. HAJ MA; NEILLY IJ; ROBBIE LA; ADEY GD; BENNETT B
      INFLUENCE OF WHITE BLOOD-CELLS ON THE FIBRINOLYTIC RESPONSE TO SEPSIS- STUDIES OF SEPTIC PATIENTS WITH OR WITHOUT SEVERE LEUKOPENIA

      British Journal of Haematology
    58. HURWITZ A; FINCIYEHESKEL Z; DUSHNIK M; MILWIDSKY A; BENCHETRIT A; YAGEL S; ADASHI EY; MAYER M
      CYTOKINE-MEDIATED REGULATION OF RAT OVARIAN-FUNCTION - INTERLEUKIN-1 INHIBITS PLASMINOGEN-ACTIVATOR ACTIVITY THROUGH THE INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)

      Molecular and cellular endocrinology
    59. SORENSEN JD; OLSEN SF; SECHER NJ; JESPERSEN J
      EFFECTS OF FISH-OIL SUPPLEMENTATION IN LATE PREGNANCY ON BLOOD-LIPIDS, SERUM URATE, COAGULATION AND FIBRINOLYSIS - A RANDOMIZED CONTROLLED-STUDY

      Fibrinolysis
    60. YORIMITSU K; SAITO T; TOYOZAKI T; ISHIDE T; OHNUMA N; INAGAKI Y
      IMMUNOHISTOCHEMICAL LOCALIZATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS INVOLVED IN ACUTE MYOCARDIAL-INFARCTION

      Heart and vessels
    61. LOSKUTOFF DJ
      REGULATION OF THE THROMBOLYTIC POTENTIAL OF THE VASCULAR WALL BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)

      Canadian journal of cardiology
    62. SHALTIEL S; SCHVARTZ I; KORCGRODZICKI B; KREIZMAN T
      EVIDENCE FOR AN EXTRACELLULAR FUNCTION FOR PROTEIN-KINASE-A

      Molecular and cellular biochemistry
    63. SERIZAWA K; URANO T; KOZIMA Y; TAKADA Y; TAKADA A
      THE POTENTIAL ROLE OF PLATELET PAI-1 IN T-PA MEDIATED CLOT LYSIS OF PLATELET-RICH PLASMA

      Thrombosis research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 15:20:03